Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoko Muramatsu is active.

Publication


Featured researches published by Yoko Muramatsu.


Respirology | 2015

Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: a case-control study.

Susumu Sakamoto; Yoko Muramatsu; Keita Satoh; Fumiaki Ishida; Naoshi Kikuchi; Go Sano; Keishi Sugino; Kazutoshi Isobe; Yujiro Takai; Sakae Homma

Treatment with pirfenidone may slow the decline in vital capacity and increase progression‐free survival (PFS) in idiopathic pulmonary fibrosis (IPF). The effects of combination therapy with inhaled N‐acetylcysteine (NAC) and pirfenidone are unclear. We assessed the effects of this combination therapy in patients with advanced IPF.


Clinical Respiratory Journal | 2017

Antioxidant nutrients in plasma of Japanese patients with chronic obstructive pulmonary disease (COPD), asthma-COPD overlap syndrome, and bronchial asthma.

Yuzo Kodama; Yuki Kishimoto; Yoko Muramatsu; Junko Tatebe; Yu Yamamoto; Nao Hirota; Yukinari Itoigawa; Ryo Atsuta; Kengo Koike; Tadashi Sato; Koich Aizawa; Kazuhisa Takahashi; Toshisuke Morita; Sakae Homma; Kuniaki Seyama; Akihito Ishigami

Few studies to date have investigated the antioxidant nutrients such as vitamin C (ascorbic acid), vitamin E (α‐tocopherol), retinol and carotenoids in plasma from patients with pulmonary disease in Japan. To clarify the role of antioxidant nutrients such as vitamin C, vitamin E, retinol and various carotenoids in plasma of Japanese patients with chronic obstructive lung diseases (COPD), asthma‐COPD overlap syndrome (ACOS) and/or bronchial asthma (BA), we compared to healthy elderly controls.


Pathology International | 2014

Malignant pleural mesothelioma mimicking the intrapulmonary growth pattern of epithelioid hemangioendothelioma

Yoko Muramatsu; Kazutoshi Isobe; Keishi Sugino; Arisa Kinoshita; Tomohiro Wada; Susumu Sakamoto; Yujiro Takai; Fumitomo Sato; Yoshinobu Hata; Megumi Wakayama; Kazutoshi Sibuya; Toshimasa Uekusa; Akira Iyoda; Sakae Homma

To the Editor: Malignant pleural mesothelioma (MPM) is a rare tumor with a very poor prognosis: median survival time from diagnosis is 9–12 months. The main pathogenic factor is asbestos exposure. In Japan, MPM incidence has been increasing rapidly since the 1960s and is expected to continue rising. Histologically, MPM can be subclassified as epithelioid (60% of cases), biphasic (30%), and sarcomatoid (10%). Some features of MPM can be visualized by computed tomography (CT); most commonly pleural effusion, pleural thickening, volume contraction, involvement of mediastinal pleura, and interlobar fissure. However, MPM is difficult to differentiate from lung adenocarcinoma with pleural dissemination on the basis of CT findings alone. MPM typically manifests locally in the hemithorax and spreads to adjacent lung tissues, predominantly by direct invasion. Parenchymal involvement in the form of pleural-based masses extending into the lung was reported in 6–10% of MPM cases in which unusual patterns of parenchymal growth were found. The unusual parenchymal growth patterns were classified as epithelioid hemangioendothelioma (EHE)-like, bronchioloalveolar carcinoma-like, desquamative interstitial pneumonia-like patterns. This EHE-like pattern was similar to an intra-alveolar growth pattern. Only sarcomatoid MPM has been reported to mimic EHE. A 72-year-old Japanese man was hospitalized for progressive dyspnea on exertion, and a chest X-ray showed right pleural effusion. He was a heavy smoker (smoking index: 1500) and had been exposed to asbestos for over 30 years at his job. Physical examination of the chest revealed marked reduction of breath sounds on the right side. Chest CT after drainage showed focal pleural thickening near the vertebral body and a peripheral intrapulmonary nodular lesion (diameter, 15 mm) in the posterior basal segment (S10) of the right lung (Fig. 1). In a sample of the pleural effusion, the Cyfra 21-1, cytokeratin 19 fragment (CYFRA) level was 6.7 ng/mL, and the hyaluronic acid level was 28 200 μg/L. Cytologic and bacteriologic examinations of the pleural effusion revealed no evidence of malignancy. Video-assisted thoracoscopic surgery (VATS) was performed to establish a definitive diagnosis. Thoracoscopy showed diffuse fibrous adhesion, multiple small nodular lesions on the parietal pleura, and a solid subpleural nodule in S10 of the right lung, with whitish thickened pleura around the nodule. A pleural biopsy obtained by VATS included several small nodular lesions. A lung biopsy of the nodule in S10 of the right lung was also obtained. Histologic examination of the biopsied parietal pleura showed features typical of biphasic MPM, namely interlacing fascicles of papillotubular formations of epithelioid cells and storiform formation of spindle cells in one lesion. Immunohistochemical staining for mesothelial markers was strongly positive for calretinin and weakly positive for Wilms tumor 1 (WT-1) and D2-40 in the epithelioid area. In the sarcomatoid area, staining was positive for calretinin, WT-1, and D2-40. Both areas were negative for carcinoembryonic antigen (CEA) and thyroid transcription factor-1 (TTF-1). The intrapulmonary nodule in the right posterior basal segment was biphasic, and both areas contained spindle and epithelioid cells. The tumor spread diffusely over the visceral pleura and infiltrated the peripheral lung. A few intracytoplasmic vacuoles were present in tumor cells in the epithelioid area. Elastica Van Gieson (EVG) staining revealed that the nodule comprised centrally hyalinized stroma and encircling


Internal Medicine | 2013

Efficacy of Pirfenidone in Patients with Advanced-stage Idiopathic Pulmonary Fibrosis

Susumu Sakamoto; Takafumi Itoh; Yoko Muramatsu; Keita Satoh; Fumiaki Ishida; Keishi Sugino; Kazutoshi Isobe; Sakae Homma


Internal Medicine | 2009

Churg-Strauss Syndrome Presenting with Diffuse Alveolar Hemorrhage and Rapidly Progressive Glomerulonephritis

Keishi Sugino; Naoshi Kikuchi; Yoko Muramatsu; Go Sano; Emiko Kusano; Kazutoshi Isobe; Susumu Sakamoto; Yujiro Takai; Chikako Hasegawa; Kazutoshi Shibuya; Kazuhito Hatanaka; Toshimasa Uekusa; Sakae Homma


Internal Medicine | 2010

Bird Fancier's Lung Which Developed in a Pigeon Breeder Presenting Organizing Pneumonia

Takafumi Ito; Keishi Sugino; Daisuke Satoh; Yoko Muramatsu; Go Sano; Keita Sato; Shinji Sakaguchi; Kazutoshi Isobe; Susumu Sakamoto; Yujiro Takai; Yoshinobu Hata; Kazutoshi Shibuya; Toshimasa Uekusa; Atsuko Kurosaki; Sakae Homma


american thoracic society international conference | 2012

Effect of inhaled N-acetylcysteine monotherapy on lung function and redox balance in idiopathic pulmonary fibrosis

Yoko Muramatsu; Keishi Sugino; Fumiaki Ishida; Junko Tatebe; Toshisuke Morita; Sakae Homma


Internal Medicine | 2009

Successful treatment with pneumonectomy for pulmonary Mycobacterium abscessus infection.

Keishi Sugino; Minaho Kobayashi; Motohide Iwata; Kyoko Gocho; Kyohei Kaburaki; Yoko Muramatsu; Fumiaki Ishida; Taito Miyazaki; Daisuke Sato; Shinji Sakaguchi; Go Sano; Emiko Kusano; Kazutoshi Isobe; Susumu Sakamoto; Yujiro Takai; Kazutoshi Shibuya; Keigo Takagi; Sakae Homma


american thoracic society international conference | 2009

Efficacy of Inhaled N-Acetylcysteine on Lung Function and Redox Balance in Idiopathic Pulmonary Fibrosis.

Fumiaki Ishida; Keishi Sugino; Yoko Muramatsu; Daisuke Sato; Shinji Sakaguchi; Go Sano; Kazutoshi Isobe; Susumu Sakamoto; Yujiro Takai; Junko Tatebe; Toshisuke Morita; Chiaki Nishimura; Sakae Homma


Molecular and Clinical Oncology | 2016

Analysis of blood neutrophil elastase, glutathione levels and pathological findings in postoperative acute exacerbation of idiopathic pulmonary fibrosis associated with lung cancer: Two case reports

Keishi Sugino; Yasuhiko Nakamura; Yoko Muramatsu; Yoshinobu Hata; Kazutoshi Shibuya; Sakae Homma

Collaboration


Dive into the Yoko Muramatsu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge